New solutions and opportunities for 21ST century companies

LISBON INVESTOR CONFERENCE

Lisboa is currently at the heart of the innovation and entrepreneurship ecosystem, supported by highly skilled and motivated companies, professionals and educational institutions.

The first day of the conference is promoted by the Family Businesses Association. Called Growth Day, it will address the theme of finance to companies, traditional solutions vs. new alternatives.

The second day will be promoted by Hovione Capital. Called Health Startup Day, it will be dedicated to startups and investors focused on health care innovation.

When?

November 7th and 8th

Museum of the Orient, Lisbon

Learn more about the

Agenda

Thursday November 7th

GROWTH DAY

09h00 |

Registration, Networking and Welcome Coffee

09h30 |

Opening time
Peter Villax, Conference Host and President of the Portuguese Family Business Association
Marcos Lagoa, Conference Chairman

09h40 |

Keynote Session: The importance of capital markets for Portugal.
Pedro Siza Vieira, Minister of the Economy (tbc)

10h00 |

Masterclass: Financing alternatives

10h30 |

Coffee Break and Networking

11h00 |

Round Table -Debt

11h45 |

Round Table: Mezzanine

12h20 |

Buffet Lunch and Networking

13h30 |

Round Table: Equity

14h00 |

Masterclass: Corporate Governance
Duarte Pitta Ferraz, NOVA SBE

14h45 |

Round Table: Corporate Governance

15h30 |

Coffee Break and Networking

15h45 |

Interview with Diane Villax, Hovione
By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

16h30 |

Closure: Conference
Conclusions by Peter Villax

16h40 |

Drinks & Networking

19h40 |

Lisbon Investor Conference Dinner at Kais Restaurant
Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon.
Ingredients for success: courage, preparation and teamwork.

The speakers

Pedro

Siza Vieira

Pedro Siza Vieira is a Portuguese lawyer and politician. From October 2017 to October 2018 he was Minister Assistant to the Prime-Minister, and he is currently, Assistant Minister to the Prime-Minister and Minister of Economy of the Portuguese Government.

Alexandra

Abreu Loureiro

Alexandra Abreu Loureiro is partner at the Brunswick Group, a reputation consulting group which leads in Portugal and in the Portuguese-speaking world.

Diane

Villax

Diane Villax is Founder Chairman of Hovione, a company she founded in 1959 with her husband, Ivan Villax. Hovione is a worldwide company with a large experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Garrett

McNamara

Garrett McNamara is a giant wave explorer, renowned for discovering and pioneering when surfing the world’s largest wave in Nazareth. Since then he has shared his experience as a leader.

Interested?

View the agenda | Buy Tickets

Learn more about the

Agenda

Friday. November 8th

HEALTH STARTUP DAY

08h00 |

Registration, Networking and Welcome Coffee

09h00 |

Opening of the Conference
Welcome Remarks – Peter Villax, Chairman Hovione Capital
Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

09h20 |

Keynote Session: Why this is a great time to invest in life sciences in Portugal.
Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

09h40 |

Therapeutics Time: Presentations by SolasCure, Immunethep and CellmAbs

10h30 |

Coffee Break and Networking

11h00 |

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics

Jury Members
Lev Osherovich, Versant Ventures (CH)
Daniela Couto, Biogeneration (NL)
Giovanni Mariggi, Medicxi (UK)
Jonathan Tobin, Arix Biosciences (UK)
Pablo Cironi, Caixa Capital Risc (ES)

12h00 |

Masterclass: How to raise capital from VCs: the winning way
Dirk Kersten, General Partner at Forbion (NL).

12h20 |

Buffet Lunch and Networking

13h30 |

Keynote Session: Lymphact: how we went from the lab to a successful exit.
Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

13h50 |

Panel – What do corporates and startups need from each other?
Richard Davis, Johnson & Johnson Innovation (UK)
David Cristina, Fosun Healthcare (UK)
Gonçalo Andrade, Nanoform (FI)
Moderation: Yvonne Redmond, Speakers Director of Web Summit

14h30 |

Digital Health Time – Presentations by Performetric and Mediceus

15h10 |

Coffee Break and Networking

15h40 |

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics

Jury Members:
David Malta, Vesalius (LU)
João Ribas, Novo Holdings (DK)
José Mesa, Alta Life Sciences (ES)
Peter Dines, Mercia Asset Management PLC (UK)

16h30 |

Closing
Peter Villax, Chairman of Hovione Capital

16h40 |

Drinks & Networking

18h00 |

Event Closing

The speakers

Jonathan

Tobin

Jonathan Tobin is an Investment Director at Arix Bioscience where he specializes in biotechnology investments. He currently sits on the board of Artios Pharma, Atox Bio and Mitoconix Bio.

Pablo

Cironi

Pablo is the Director of Life Science Investment Funds at Caixa Capital Risc. He currently serves on the Board of Medlumics, Aelix Therapeutics, Minoryx Therapeutics, iProteos, Proteodesign and Sanifit.

Giovanni

Mariggi

Giovanni is a Partner at Medicxi and has been with the firm since its inception in 2016. Prior to Medicxi, Giovanni was a Principal at Index Ventures for four years, having joined in 2012.

Yvonne

Redmond

Yvonne Redmond is the Speakers Director at Europe’s biggest science and technology event, the Web Summit. Held each year in Lisbon, Portugal, the Web Summit draws 70.000 people, 2.800 journalists and 18 million Facebook views.

David

Malta

David Braga Malta is a Venture Partner at Vesalius Biocapital. He previously founded NeurIMM, Cell2B and BoostPharma, where he serves(ed) as a manager. He was previously a member of Caixa Capital’s venture capital team.

Daniela

Couto

Daniela Couto is a Principal at Biogeneration Ventures. Daniela is the managing director of Staten Biotech and serves on the board of Catalym. Daniela previously was CEO at Cell2B, a life sciences company that she co-founded dedicated to treat immune and inflammatory diseases.

Rick

Davis

Rick is Senior Director, New Ventures and Transactions, Oncology at Johnson & Johnson Innovation in London. In this role, Rick leverages his experience and knowledge of the scientific and biotech landscape to identify and evaluate external opportunities and deliver transformative innovation into the pipeline.

Bruno

Silva-Santos

Prof. Bruno Silva-Santos is an Associate Professor at the Faculty of Medicine of the University of Lisbon and Principal Investigator at João Lobo Antunes Molecular Institute of Medicine in Lisbon.

Carlos

Moedas

Carlos Moedas is a Portuguese civil engineer, economist and politician. Between 2011 and 2014 he was appointed Assistant Secretary of State in the XIX Constitutional Government of Portugal. Since November 1st Moedas is European Commissioner for Research, Science and Innovation.

David

Cristina

Executive Director at Fosun International, a leading Chinese conglomerate, where he currently leads the Healthcare Investment team for Europe. He has over 10 years of experience in venture creation, VC and PE experience across US, EU and China. He was on the board of Lymphact, Immunethep and Tonic App.

Peter

Dines

Peter joined Mercia Asset Management PLC (UK) in 2015 as Head of Life Sciences & Biosciences. He is currently responsible for investing in new companies in the life sciences sector, with over 20 years’ experience. In addition became Chief Operating Officer in 2018.

José António

Mesa

Jose Mesa is a Partner at Alta Life Sciences where he invests in drug development and medical devices. Jose was previously Investment Director at Caixa Capital Risc where he lead analysis, negotiation and structuring of investments in life sciences companies.

João

Ribas

João Ribas joined Novo Seeds in 2018 as an Investment Associate. Previously, he was an analyst at M Ventures. Among other activities, he started several new ventures in the USA and Europe.

Dirk

Kersten

Dirk Kersten is a General Partner at Forbion and focuses primarily on new investments. Dirk was previously a Partner at Gilde Healthcare, where he led their Boston/US operations.

Gonçalo

Andrade

Chief of Business Operations at Nanoform. Gonçalo is a Biochemist by training and has over 20 years’ experience in the pharmaceutical and venture capital industries.

Peter

Villax

Peter Villax is currently Chairman of Hovione Capital, a VC firm focused on investing in life sciences’ projects across Europe. Peter is the President of the Portuguese Family Business Association and Board Member of the European Family Businesses Federation.

Ricardo

Perdigão Henriques

Ricardo Perdigão Henriques is the CEO of Hovione Capital, a healthcare-specialized VC fund based in Portugal investing in early-stage life sciences projects across Europe.

Lev

Osherovich

Lev is Director of Innovation and Sourcing at Versant Ventures where he identifies and evaluates early-stage drug discovery projects, bridging academic and industry knowledge to uncover unexpected therapeutic opportunities.

Get to know the Startups

Interested?

View the agenda | Buy Tickets

LISBON INVESTOR CONFERENCE

November 7th and 8th

Agenda

GROWTH DAY

09h00 |

Registration, Networking and Welcome Coffee

09h30 |

Opening time Peter Villax, Conference Host and President of the Portuguese Family Business Association Marcos Lagoa, Conference Chairman

09h40 |

Keynote Session: The importance of capital markets for Portugal. Pedro Siza Vieira, Minister of the Economy (tbc)

10h00 |

Masterclass: Financing alternatives

10h30 |

Coffee Break and Networking

11h00 |

Round Table -Debt

11h45 |

Round Table: Mezzanine

12h20 |

Buffet Lunch and Networking

13h30 |

Round Table: Equity

14h00 |

Masterclass: Corporate Governance Duarte Pitta Ferraz, NOVA SBE

14h45 |

Round Table: Corporate Governance

15h30 |

Coffee Break and Networking

15h45 |

Interview with Diane Villax, Hovione By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

16h30 |

Closure: Conference Conclusions by Peter Villax

16h40 |

Drinks & Networking

19h40 |

Lisbon Investor Conference Dinner at Kais Restaurant Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon. Ingredients for success: courage, preparation and teamwork.

The speakers

Interested?

Agenda

HEALTH STARTUP DAY

08h00 |

Registration, Networking and Welcome Coffee

09h00 |

Opening of the Conference Welcome Remarks – Peter Villax, Chairman Hovione Capital Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

09h20 |

Keynote Session: Why this is a great time to invest in life sciences in Portugal. Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

09h40 |

Therapeutics Time: Presentations by SolasCure, Immunethep and CellmAbs

10h30 |

Coffee Break and Networking

11h00 |

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics Jury Members Lev Osherovich, Versant Ventures (CH) Daniela Couto, Biogeneration (NL) Giovanni Mariggi, Medicxi (UK) Jonathan Tobin, Arix Biosciences (UK) Pablo Cironi, Caixa Capital Risc (ES)

12h00 |

Masterclass: How to raise capital from VCs: the winning way Dirk Kersten, General Partner at Forbion (NL).

12h20 |

Buffet Lunch and Networking

13h30 |

Keynote Session: Lymphact: how we went from the lab to a successful exit. Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

13h50 |

Panel – What do corporates and startups need from each other? Richard Davis, Johnson & Johnson Innovation (UK) David Cristina, Fosun Healthcare (UK) Gonçalo Andrade, Nanoform (FI) Moderation: Yvonne Redmond, Speakers Director of Web Summit

14h30 |

Digital Health Time – Presentations by Performetric and Mediceus

15h10 |

Coffee Break and Networking

15h40 |

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics Jury Members: David Malta, Vesalius (LU) João Ribas, Novo Holdings (DK) José Mesa, Alta Life Sciences (ES) Peter Dines, Mercia Asset Management PLC (UK)

16h30 |

Closing Peter Villax, Chairman of Hovione Capital

16h40 |

Drinks & Networking

18h00 |

Event Closing

The speakers

Interested?

Latest News

Opening time
Peter Villax, Conference Host and President of the Portuguese Family Business Association
Marcos Lagoa, Conference Chairman

Keynote Session: The importance of capital markets for Portugal.
Pedro Siza Vieira, Minister of the Economy (tbc)

Masterclass: Corporate Governance
Duarte Pitta Ferraz, NOVA SBE

Interview with Diane Villax, Hovione
By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

Closure: Conference
Conclusions by Peter Villax

Lisbon Investor Conference Dinner at Kais Restaurant
Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon.
Ingredients for success: courage, preparation and teamwork.

Opening of the Conference
Welcome Remarks – Peter Villax, Chairman Hovione Capital
Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

Keynote Session: Why this is a great time to invest in life sciences in Portugal.
Carlos Moedas, European Commissioner for Research, Science and Innovation (tbc)

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics

Jury Members
Lev Osherovich, Versant Ventures (CH)
Daniela Couto, Biogeneration (NL)
Giovanni Mariggi, Medicxi (UK)
Jonathan Tobin, Arix Biosciences (UK)
Pablo Cironi, Caixa Capital Risc (ES)

Masterclass: How to raise capital from VCs: the winning way
Dirk Kersten, General Partner at Forbion (NL).

Keynote Session: Lymphact: how we went from the lab to a successful exit.
Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

Panel – What do corporates and startups need from each other?
Richard Davis, Johnson & Johnson Innovation (UK)
David Cristina, Fosun Healthcare (UK)
Gonçalo Andrade, Nanoform (FI)
Moderation: Yvonne Redmond, Speakers Director of Web Summit

Medtech Time: Presentations by Adapttech, Delox and GlyCardial Diagnostics

Jury Members:
David Malta, Vesalius (LU)
João Ribas, Novo Holdings (DK)
José Mesa, Alta Life Sciences (ES)
Peter Dines, Mercia Asset Management PLC (UK)

Closing
Peter Villax, Chairman of Hovione Capital